Search Results 231-240 of 17308 for hba1c

1. Investigational Extended Wear Insulin Infusion Set During Home Use for Type 1 Diabetes - Mayo Clinic

   HbA1c < 9.0% in the last 6 months. If not available must be performed for study qualification. Willing to implement and adhere to pump alert/alarm settings ...

2. A Study to Evaluate Electrical Nerve Block for Amputation Pain - Mayo Clinic

   Uncontrolled diabetes as defined by HbA1c > 8.0. Spasticity in their residual limb such that the subject cannot achieve volitional full range of motion (ROM) ...

3. Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis (NAVIGATE) - Mayo Clinic

   ... [HbA1c] ≥ 6.5%, or on anti-diabetic medication for at least 1 year); or dyslipidemia (triglycerides ≥150 mg/dL or on drug therapy for hypertriglyceridemia ...

4. A Study To Determine The Safety Of PEP In Skin Graft Wounds - Mayo Clinic

   Patients with poorly controlled diabetes mellitus (HbA1C ≥ 8%). Patients with known peripheral neuropathy, or known concomitant vascular problems (such as ...

5. Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis - Mayo Clinic

   Subjects with uncontrolled diabetes, as defined by HbA1c > 7%. 9. Subjects who have used the following medications: - Methotrexate within 90 days of ...

6. Type 1 diabetes - Doctors and departments - Mayo Clinic

   Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

7. Low hemoglobin count Causes - Mayo Clinic

   A low hemoglobin count is a commonly seen blood test result. Hemoglobin (Hb or Hgb) is a protein in red blood cells that carries oxygen throughout the body.

8. Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer - Mayo Clinic

   mg/dL [7.7 mmol/L], or glycosylated hemoglobin [HbA1c] level of >6.4%). 3. Known intolerance to alpelisib or any of its excipients. 4. Patient is currently ...

9. Phase 3 Pivotal Trial Comparing CARTISTEM® And Surgical Comparator For Knee Cartilage Lesions And Osteoarthritis - Mayo Clinic

   Uncontrolled diabetes with HbA1c \> 8% as determined by documented medical history. 19. Infectious disease requiring parenteral administration of ...

10. Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy - Mayo Clinic

    A fasting glucose ≥ 126mg/dl or an HbA1c ≥ 6.5% will be taken as evidence of type 2 diabetes and therefore patients will be deemed ineligible for ...